Activity:

AJCC Melanoma Staging: Impact on Current Practices

CME Course Duration:

Start Date: 01-19-2010
End Date: 01-18-2011

Speaker: Susan M. Swetter, MD Professor of Dermatology Director, Pigmented Lesion & Melanoma Program Stanford University Medical Center/VA Palo Alto Health Care System Stanford, CA

Featured Topic Information: Please click here to view a webcast (registration required) Please click here to view the slide library (registration required) Please click here to listen to the audio (registration required) Please click here to take the post test and evaluation (registration required) Please click here if you have any comments or questions relating to this topic

Target Audience

This activity is directed toward surgical oncologists, general surgeons, oncology nurses, medical oncologists, dermatologists, and other healthcare professionals who screen for and/or treat melanoma.

Educational Objective

• Identify changes in the 7th Edition of the American Joint Committee on Cancer (AJCC) melanoma staging system compared with the previous edition
• Describe the current status of the sentinel lymph node biopsy (SLNB) in melanoma staging, including patients with thin (≤ 1 mm) cutaneous melanoma
• Identify other factors associated with SLN positivity

Faculty Disclosure Statement

Dr. Susan M. Swetter has disclosed she receives grant/research support from Schering-Plough Corporation.

Physician/Nurse Accreditation Statement

The University of Pittsburg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Pittsburgh School of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits. Each physician should claim only those credits commensurate with the extent of his or her participation in the activity.

1 contact hour of Continuing Nursing Education will be granted by the University of Pittsburgh Medical Center. The University of Pittsburgh Medical Center is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association (PSNA), an accredited approver by the American Nurses Credentialing Centers Commission on Accreditation.

We gratefully acknowledge an educational grant from Schering-Plough Corporation in support of this activity.

This CME program represents the views and opinions of the individual faculty for each case and does not constitute the opinion or endorsement of the editors, the advisory board, the publishing staff, Paradigm Medical Communications, the UPMC Center for Continuing Education in the Health Sciences, UPMC/University of Pittsburgh Medical Center or affiliates, or University of Pittsburgh School of Medicine.

Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions, including without limitation, FDA-approved uses, and any off-label uses.